148 related articles for article (PubMed ID: 21884211)
21. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
22. Histological features of melanoma sentinel lymph node metastases associated with status of the completion lymphadenectomy and rate of subsequent relapse.
Govindarajan A; Ghazarian DM; McCready DR; Leong WL
Ann Surg Oncol; 2007 Feb; 14(2):906-12. PubMed ID: 17136471
[TBL] [Abstract][Full Text] [Related]
23. Validation of the S classification of sentinel lymph node and microanatomic location of sentinel lymph node metastases to predict additional lymph node involvement and overall survival in breast cancer patients.
Fink AM; Wondratsch H; Lass H; Janauer M; Sevelda P; Salzer H; Jurecka W; Ulrich W; Chott A; Steiner A
Ann Surg Oncol; 2011 Jun; 18(6):1691-7. PubMed ID: 21249455
[TBL] [Abstract][Full Text] [Related]
24. The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma.
Paek SC; Griffith KA; Johnson TM; Sondak VK; Wong SL; Chang AE; Cimmino VM; Lowe L; Bradford CR; Rees RS; Sabel MS
Cancer; 2007 Jan; 109(1):100-8. PubMed ID: 17146784
[TBL] [Abstract][Full Text] [Related]
25. Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy?
Mays MP; Martin RC; Burton A; Ginter B; Edwards MJ; Reintgen DS; Ross MI; Urist MM; Stromberg AJ; McMasters KM; Scoggins CR
Cancer; 2010 Mar; 116(6):1535-44. PubMed ID: 20108306
[TBL] [Abstract][Full Text] [Related]
26. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?
Nahabedian MY; Tufaro AP; Manson PN
Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009
[TBL] [Abstract][Full Text] [Related]
27. Prognostic heterogeneity after the excision of lymph node metastases in patients with cutaneous melanoma.
Pilko G; Besic N; Zgajnar J; Hocevar M
Surg Oncol; 2011 Mar; 20(1):26-34. PubMed ID: 19900803
[TBL] [Abstract][Full Text] [Related]
28. Factors predictive of nonsentinel lymph node involvement and clinical outcome in melanoma patients with metastatic sentinel lymph node.
Rossi CR; De Salvo GL; Bonandini E; Mocellin S; Foletto M; Pasquali S; Pilati P; Lise M; Nitti D; Rizzo E; Montesco MC
Ann Surg Oncol; 2008 Apr; 15(4):1202-10. PubMed ID: 18165880
[TBL] [Abstract][Full Text] [Related]
29. Sentinel lymph node biopsy in patients with Stage I/II melanoma: Clinical experience and literature review.
Gipponi M; Di Somma C; Peressini A; Solari N; Gliori S; Nicolo G; Schenone F; Queirolo P; Sertoli MR; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):133-40. PubMed ID: 14991885
[TBL] [Abstract][Full Text] [Related]
30. Assessment of a new scoring system for predicting non-sentinel node positivity in sentinel node-positive melanoma patients.
Wevers KP; Murali R; Bastiaannet E; Scolyer RA; Suurmeijer AJ; Thompson JF; Hoekstra HJ
Eur J Surg Oncol; 2013 Feb; 39(2):179-84. PubMed ID: 23137997
[TBL] [Abstract][Full Text] [Related]
31. Tumour regression does not increase the risk of sentinel node involvement in thin melanomas.
Cecchi R; Pavesi M; Buralli L; Innocenti S; De Gaudio C
Chir Ital; 2008; 60(2):257-60. PubMed ID: 18689175
[TBL] [Abstract][Full Text] [Related]
32. Sentinel lymph node micrometastasis may predict non-sentinel involvement in cutaneous melanoma patients.
Glumac N; Hocevar M; Zadnik V; Snoj M
J Surg Oncol; 2008 Jul; 98(1):46-8. PubMed ID: 18452214
[TBL] [Abstract][Full Text] [Related]
33. Sentinel lymph node biopsy in elderly irish patients with malignant melanoma.
Moran DE; Smith MJ; O'Sullivan MJ; Bannon H; Crotty TB; Collins CD; Skehan SJ; O'Higgins N; McDermott EW; Evoy D; Hill AD
Ir Med J; 2007 Apr; 100(4):422-4. PubMed ID: 17566474
[TBL] [Abstract][Full Text] [Related]
34. Sentinel lymph node biopsy in patients with thin melanoma: occurrence of nodal metastases and its prognostic value.
Vermeeren L; Van der Ent F; Sastrowijoto P; Hulsewé K
Eur J Dermatol; 2010; 20(1):30-4. PubMed ID: 19889594
[TBL] [Abstract][Full Text] [Related]
35. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
[TBL] [Abstract][Full Text] [Related]
36. [Anatomo-pathologic study of sentinel lymph nodes in melanoma. Analysis of 200 cases].
Riccioni L; Morigi F; Naldi S; Polverelli M; Morelli R; Fiscelli O; Landi G; Giangaspero F
Pathologica; 1999 Aug; 91(4):242-8. PubMed ID: 10630072
[TBL] [Abstract][Full Text] [Related]
37. [Sentinel lymph nodes in skin melanoma].
Gesuelli GC; Berbellini A; Brianzoni E; Fattori S; Simonacci M; Sigona M; Cardarelli MA
Ann Ital Chir; 2000; 71(2):169-76. PubMed ID: 10920487
[TBL] [Abstract][Full Text] [Related]
38. The detection and significance of melanoma micrometastases in sentinel nodes.
Scolyer RA; Murali R; Satzger I; Thompson JF
Surg Oncol; 2008 Sep; 17(3):165-74. PubMed ID: 18639451
[TBL] [Abstract][Full Text] [Related]
39. Analysis of sentinel node involvement in gastric cancer.
Morita D; Tsuda H; Ichikura T; Kimura M; Aida S; Kosuda S; Inazawa J; Mochizuki H; Matsubara O
Clin Gastroenterol Hepatol; 2007 Sep; 5(9):1046-52. PubMed ID: 17632042
[TBL] [Abstract][Full Text] [Related]
40. Sentinel node identification by scintigraphic methods in cutaneous melanoma.
Dias Moreira R; Altino de Almeida S; Maliska Guimarães CM; Resende JF; Gutfilen B; Barbosa da Fonseca LM
J Exp Clin Cancer Res; 2005 Jun; 24(2):181-5. PubMed ID: 16110749
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
